![PDF) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and PDF) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and](https://www.researchgate.net/profile/John-Kjekshus/publication/262044567/figure/fig2/AS:614204193128458@1523449099338/Glycaemic-continuum-and-cardiovascular-disease_Q320.jpg)
PDF) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and
![PDF) CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management PDF) CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management](https://i1.rgstatic.net/publication/326514429_CardioDiabetes_Core_Competencies_for_Cardiovascular_Clinicians_in_a_Rapidly_Evolving_Era_of_Type_2_Diabetes_Management/links/5e765fd4299bf1892cfef3b7/largepreview.png)
PDF) CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management
![PDF) Consenso latinoamericano de hipertensión en pacientes con diabetes tipo 2 y síndrome metabólico PDF) Consenso latinoamericano de hipertensión en pacientes con diabetes tipo 2 y síndrome metabólico](https://i1.rgstatic.net/publication/259511508_Consenso_latinoamericano_de_hipertension_en_pacientes_con_diabetes_tipo_2_y_sindrome_metabolico/links/5f0dc8e5a6fdcc3ed7056fc7/largepreview.png)
PDF) Consenso latinoamericano de hipertensión en pacientes con diabetes tipo 2 y síndrome metabólico
![Partial inhibition of the ubiquitin–proteasome system ameliorates cardiac dysfunction following ischemia–reperfusion in the presence of high glucose – topic of research paper in Biological sciences. Download scholarly article PDF and read for Partial inhibition of the ubiquitin–proteasome system ameliorates cardiac dysfunction following ischemia–reperfusion in the presence of high glucose – topic of research paper in Biological sciences. Download scholarly article PDF and read for](https://cyberleninka.org/viewer_images/608062/f/1.png)
Partial inhibition of the ubiquitin–proteasome system ameliorates cardiac dysfunction following ischemia–reperfusion in the presence of high glucose – topic of research paper in Biological sciences. Download scholarly article PDF and read for
![Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents | International Journal of Obesity Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents | International Journal of Obesity](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fijo.2009.186/MediaObjects/41366_2009_Article_BFijo2009186_Fig1_HTML.jpg)
Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents | International Journal of Obesity
![PDF) Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents PDF) Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents](https://i1.rgstatic.net/publication/26853887_Associations_of_insulin-like_growth_factor_binding_protein-3_gene_polymorphisms_with_IGF-I_activity_and_lipid_parameters_in_adolescents/links/0c960536dff3dd8073000000/largepreview.png)
PDF) Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents
![SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism | SpringerLink SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10741-021-10096-8/MediaObjects/10741_2021_10096_Fig2_HTML.png)